Two Voyager Therapeutics executives step down amid pivot

Voyager Therapeutics (Nasdaq: VYGR) is losing two executives this spring as the gene therapy company shifts its focus to engineering capsids for adeno-associated viruses (AAVs) that deliver gene-altering treatments.